One in five Brits want restaurants to start serving 'fat jab menus,' according to new research from Lightspeed, an ePOS and payments platform. Around 20% of respondents said restaurants should offer special dishes for customers using weight-loss drugs.
Survey Reveals Demand for Smaller Portions and Calorie Labels
The survey also found that more than one in four (28%) think restaurants should serve smaller portions to help tackle obesity levels. Additionally, over a third (35%) want calories to be shown clearly on menus, as diners become more conscious about their food choices.
Liam Crooks, Managing Director of EMEA Hospitality at Lightspeed, said: 'Brits clearly aren't looking to give up eating out, but they are becoming more conscious about what and how much they're ordering. As weight-loss medications reportedly become more widely used, we're starting to see a shift in what some customers want from the restaurant experience. This isn't about completely reinventing menus, it's about offering greater flexibility, whether that's smaller portions, clearer calorie information or more choice for diners with different needs and appetites.'
City Support for Weight-Management Menus
The cities most likely to back weight-management menus were Leeds (38%), followed by Brighton (33%), Nottingham (31%), Liverpool (27%), and Manchester (25%).
This trend follows the launch of what was dubbed the UK's first 'fat jab' menu at celeb-favourite Otto's in central London. The French restaurant created a £350 six-course 'small appetite' menu for diners who can no longer manage bigger portions while using weight-loss jabs. The luxury menu includes caviar, scallop, lobster, foie gras, truffle, veal, Bresse chicken, and a coconut milk dessert.
Founder Otto Tepasse said the idea came after one regular customer complained he could barely eat out because restaurant portions were too large. The menu was designed to show diners could still enjoy high-end food while using Ozempic-style drugs, rather than having to skip eating out altogether.
Supermarkets Join the Trend
The trend has now moved beyond posh restaurants and into the supermarket aisle. Co-op has launched a 'Good Fuel' range aimed at shoppers whose appetites have reduced while using drugs such as Wegovy and Mounjaro. The meals include smaller, protein-rich dishes such as chicken curry, teriyaki noodles, chicken pasta, and a vegetarian grains pot, priced from £3.50.
M&S and Morrisons have also moved into the same space, with retailers increasingly targeting shoppers who want lower-calorie, nutrient-dense meals in smaller portions.
Impact of Weight-Loss Drug Use
More than 1.5 million people in the UK are now thought to be using weight-loss drugs, meaning many are unable to eat as much as they did before. The jabs work by helping people feel fuller for longer and reducing appetite, which can make traditional restaurant portions harder to finish.
Hospitality experts say the boom could reshape menus, with more diners looking for lighter dishes, smaller plates, and clearer nutritional information. However, the research suggests Brits are not looking to give up meals out altogether. Instead, many want restaurants to offer more flexible choices so people can still enjoy dining out while managing weight-loss goals, health needs, or reduced appetites.
